These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21646472)
1. Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1. Mayes PA; Dolloff NG; Daniel CJ; Liu JJ; Hart LS; Kuribayashi K; Allen JE; Jee DI; Dorsey JF; Liu YY; Dicker DT; Brown JM; Furth EE; Klein PS; Sears RC; El-Deiry WS Cancer Res; 2011 Aug; 71(15):5265-75. PubMed ID: 21646472 [TBL] [Abstract][Full Text] [Related]
2. The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia. Zhang J; Zhou L; Zhao S; Dicker DT; El-Deiry WS Cell Cycle; 2017 Jun; 16(12):1193-1200. PubMed ID: 28486050 [TBL] [Abstract][Full Text] [Related]
3. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells. Le XF; Mao W; He G; Claret FX; Xia W; Ahmed AA; Hung MC; Siddik ZH; Bast RC J Natl Cancer Inst; 2011 Sep; 103(18):1403-22. PubMed ID: 21813412 [TBL] [Abstract][Full Text] [Related]
4. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280 [TBL] [Abstract][Full Text] [Related]
5. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis. Pencreach E; Guérin E; Nicolet C; Lelong-Rebel I; Voegeli AC; Oudet P; Larsen AK; Gaub MP; Guenot D Clin Cancer Res; 2009 Feb; 15(4):1297-307. PubMed ID: 19190131 [TBL] [Abstract][Full Text] [Related]
6. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma. Liu Q; Mier JW; Panka DJ Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745 [TBL] [Abstract][Full Text] [Related]
7. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3. Liu F; Liu Q; Yang D; Bollag WB; Robertson K; Wu P; Liu K Cancer Res; 2011 Nov; 71(21):6807-16. PubMed ID: 21911457 [TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice. Sasaki T; Kitadai Y; Nakamura T; Kim JS; Tsan RZ; Kuwai T; Langley RR; Fan D; Kim SJ; Fidler IJ Neoplasia; 2007 Dec; 9(12):1066-77. PubMed ID: 18084614 [TBL] [Abstract][Full Text] [Related]
10. Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer. Büchler P; Reber HA; Roth MM; Shiroishi M; Friess H; Hines OJ Neoplasia; 2007 Feb; 9(2):119-27. PubMed ID: 17356708 [TBL] [Abstract][Full Text] [Related]
11. Hypoxic inactivation of glycogen synthase kinase-3β promotes gastric tumor growth and angiogenesis by facilitating hypoxia-inducible factor-1 signaling. Ko YS; Cho SJ; Park J; Choi Y; Lee JS; Youn HD; Kim WH; Kim MA; Park JW; Lee BL APMIS; 2016 Sep; 124(9):748-56. PubMed ID: 27365055 [TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells. Tammali R; Saxena A; Srivastava SK; Ramana KV J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240 [TBL] [Abstract][Full Text] [Related]
13. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3. Nagaraju GP; Park W; Wen J; Mahaseth H; Landry J; Farris AB; Willingham F; Sullivan PS; Proia DA; El-Hariry I; Taliaferro-Smith L; Diaz R; El-Rayes BF Angiogenesis; 2013 Oct; 16(4):903-17. PubMed ID: 23838996 [TBL] [Abstract][Full Text] [Related]
15. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Ghosh JC; Altieri DC Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644 [TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Liao X; Zhang L; Thrasher JB; Du J; Li B Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy. Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362 [TBL] [Abstract][Full Text] [Related]
18. CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth. Warfel NA; Dolloff NG; Dicker DT; Malysz J; El-Deiry WS Cell Cycle; 2013 Dec; 12(23):3689-701. PubMed ID: 24189531 [TBL] [Abstract][Full Text] [Related]
19. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions. Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797 [TBL] [Abstract][Full Text] [Related]
20. GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells. Wu YY; Hsieh CT; Chiu YM; Chou SC; Kao JT; Shieh DC; Lee YJ PLoS One; 2018; 13(12):e0208094. PubMed ID: 30557366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]